Drugs / LEO 29102
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT01466478 | Nov → Dec 2011 | psoriasis | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT01447758 | Sep 2011 → Mar 2013 | atopic eczema | LEO Pharma | Terminated | No outcome recorded |
| Phase 1 | NCT01423656 | Aug 2011 → Nov 2012 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT00958516 | Sep → Oct 2009 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
| Phase 1 | NCT00891709 | Mar → Jun 2009 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01037881 | Dec 2009 → Jun 2010 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
| Phase 2 | NCT00875277 | Apr → May 2009 | psoriasis | LEO Pharma | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01005823 Comparator | Oct 2009 → May 2010 | atopic eczema | LEO Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LEO 29102 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01423656 ↗ |
| Route | Other | “LEO 29102 is administered cutaneously as single and multiple doses” NCT00891709 ↗ |